1 to 10 of 57 Results
Nov 18, 2024 -
Supplementary Material of the Article "Innate-immune cell distribution in pediatric HIV patients and uninfected controls"
Adobe PDF - 100.3 KB -
MD5: 7456a9e7a01bfd73705ad203da5d9de4
|
Nov 18, 2024 -
Supplementary Material of the Article "Innate-immune cell distribution in pediatric HIV patients and uninfected controls"
Adobe PDF - 787.5 KB -
MD5: 7d11f8dd9be1dcbbf6163d2176e49c31
Supplementary Material of the Article "Innate-immune cell distribution in pediatric HIV patients and uninfected controls" |
Adobe PDF - 23.6 KB -
MD5: 02f9c362c02c778d05a1e6058f7f28a1
|
Adobe PDF - 128.8 KB -
MD5: 685be2a28b9ca44cc28e91bca58bb402
Supplementary Material of the Article "Long-term chronic infection of a young immunocompromised patient by the SARS-CoV-2 P.2 VOI" |
Adobe PDF - 127.3 KB -
MD5: e035762de4438d125d5ed0e5cc49b18e
|
Adobe PDF - 132.2 KB -
MD5: 8397e26bad13c8d9f44f74503a1c25c5
Supplementary Material of the Article "Dynamics of communication on measles vaccination on digital platforms in the Brazilian context: challenges and perspectives" |
Adobe PDF - 10.1 KB -
MD5: 0237950de0a56242af8d4802cc36a6f8
|
Adobe PDF - 250.0 KB -
MD5: 13754f35817b2f2acfc4cc634a407093
Supplementary Material of the Article "Trends in antimicrobial susceptibility patterns in Salmonella from human and nonhuman sources in the Sao Paulo State, Brazil, 2016-2023" |
Sep 17, 2024 -
Supplementary Material of the Article "Evaluation of nitazoxanide in the treatment of experimental murine neurotoxoplasmosis"
Adobe PDF - 19.8 KB -
MD5: 6469ca75ce72e9a41841b17faa5ea601
|
Sep 17, 2024 -
Supplementary Material of the Article "Evaluation of nitazoxanide in the treatment of experimental murine neurotoxoplasmosis"
Adobe PDF - 155.0 KB -
MD5: 9b33a303e4b814d75cd916cd9e72af7f
Supplementary Material of the Article "Evaluation of nitazoxanide in the treatment of experimental murine neurotoxoplasmosis" |